Home › Compare › RTMFF vs JNJ

RTMFF vs JNJ: Dividend Comparison 2026

RTMFF yields 5714.29% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RTMFF wins by $228153224412509.56M in total portfolio value
10 years
RTMFF
RTMFF
● Live price
5714.29%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$228153224412509.59M
Annual income
$220,560,399,839,122,060,000.00
Full RTMFF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — RTMFF vs JNJ

📍 RTMFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRTMFFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RTMFF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
RTMFF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RTMFF
Annual income on $10K today (after 15% tax)
$485,714.29/yr
After 10yr DRIP, annual income (after tax)
$187,476,339,863,253,750,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, RTMFF beats the other by $187,476,339,863,253,750,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RTMFF + JNJ for your $10,000?

RTMFF: 50%JNJ: 50%
100% JNJ50/50100% RTMFF
Portfolio after 10yr
$114076612206254.81M
Annual income
$110,280,199,919,561,030,000.00/yr
Blended yield
96.67%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

RTMFF
No analyst data
Altman Z
-49.6
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RTMFF buys
0
JNJ buys
0
No recent congressional trades found for RTMFF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRTMFFJNJ
Forward yield5714.29% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$228153224412509.59M ✓$20.0K
Annual income after 10y$220,560,399,839,122,060,000.00 ✓$827.78
Total dividends collected$227641622319776.13M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RTMFF vs JNJ ($10,000, DRIP)

YearRTMFF PortfolioRTMFF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$582,129$571,428.57$10,676$355.77+$571.5K → RTMFF
2$31,711,186$31,088,308.22$11,407$389.39+$31.70M → RTMFF
3$1,616,661,128$1,582,730,159.44$12,198$426.53+$1616.65M → RTMFF
4$77,139,944,357$75,410,116,950.20$13,056$467.62+$77139.93M → RTMFF
5$3,445,379,409,484$3,362,839,669,021.90$13,987$513.12+$3445379.40M → RTMFF
6$144,058,436,084,716$140,371,880,116,567.28$14,998$563.56+$144058436.07M → RTMFF
7$5,639,412,164,337,400$5,485,269,637,726,755.00$16,098$619.52+$5639412164.32M → RTMFF
8$206,716,597,857,094,600$200,682,426,841,253,570.00$17,295$681.69+$206716597857.08M → RTMFF
9$7,096,097,732,137,874,000$6,874,910,972,430,782,000.00$18,599$750.82+$7096097732137.86M → RTMFF
10$228,153,224,412,509,600,000$220,560,399,839,122,060,000.00$20,022$827.78+$228153224412509.56M → RTMFF

RTMFF vs JNJ: Complete Analysis 2026

RTMFF — Stock

RT Minerals Corp, a junior exploration company, engages in the acquisition, exploration, and evaluation of mineral properties in Canada. It also explores for gold and base metals. The company owns a 100% interest in the Norwalk gold property comprising three unpatented mineral claims that includes 29 units covering an area of 445 hectares located in Wawa, Ontario. It also holds an option to acquire a 100% interest in the Link-Catharine RLDZ gold property that consists of 15 unpatented single cell mining claims covering an area of 220 hectares in one claim block located in the Town of Kirkland Lake, Ontario. The company was incorporated in 2007 and is headquartered in Vancouver, Canada.

Full RTMFF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this RTMFF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RTMFF vs SCHDRTMFF vs JEPIRTMFF vs ORTMFF vs KORTMFF vs MAINRTMFF vs ABBVRTMFF vs MRKRTMFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.